TLR2 and myeloid sarcoma: Studies have suggested that signaling through Toll-like receptor 2 (TLR2) plays a critical role in the inflammatory pathogenesis of MS and EAE [10–12], but only few studies have investigated a role for TLR2 signaling in remyelination.